Skip to main content
. Author manuscript; available in PMC: 2011 Feb 3.
Published in final edited form as: Vaccine. 2009 Nov 25;28(5):1209. doi: 10.1016/j.vaccine.2009.11.030

Figure 1. Disposition of subjects and cohorts analyzed.

Figure 1

Out of 273 screened volunteers, 165 subjects were assessed as being eligible for enrolment and allocated to the three study groups. In total, ten subjects were excluded from the per-protocol analysis e.g. due to premature study discontinuation, violation of visit window and seropositivity at study start.